{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:18:01Z","timestamp":1791357481407,"version":"4.3.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Psychopharmacol"],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>To compare objective and subjective weight gain of second-generation antipsychotics in schizophrenia and bipolar disorder.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>English-language literature published and cited in PubMed (MEDLINE) from January 1966 to December 2015 was searched with the keywords <jats:italic toggle=\"yes\">antipsychotic<\/jats:italic>, <jats:italic toggle=\"yes\">atypical antipsychotic, or generic\/brand name of atypical antipsychotics, and schizophrenia, bipolar disorder, bipolar mania, or bipolar depression<\/jats:italic>, and <jats:italic toggle=\"yes\">safety, tolerability, weight gain<\/jats:italic>, and <jats:italic toggle=\"yes\">randomized, placebo-controlled clinical trials<\/jats:italic>. The absolute risk increases and the numbers needed to treat to harm (NNH) for \u22657% weight gain (objective) and self-report weight gain (subjective) were estimated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In schizophrenia, the NNH for 7% or greater weight gain ranged from 5 to 62, and the NNH for self-reported weight gain was from 11 to \u2212224. The ratio of self-reported NNH to 7% or greater NNH was from 1.5 to 8.0. In bipolar mania, the NNH for 7% or greater weight gain ranged from 7 to \u2212101 and the NNH for self-reported weight gain was from 13 to 84. The ratio of self-reported NNH to 7% or greater NNH was from 0.9 to 2.5. In bipolar depression, the NNH for 7% or greater weight gain ranged from 5 to 69, and the NNH for self-reported weight gain was from 8 to 17. The ratio of self-reported NNH to 7% or greater NNH was 1.2 to 1.6.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Subjective reporting underestimated the risk of antipsychotic-related weight gain compared with objectively measured weight change. Self-awareness of antipsychotic-related weight gain was lower in patients with schizophrenia than in patients with bipolar disorder. Measuring weight change during antipsychotic treatment should be a routine practice.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/jcp.0000000000000596","type":"journal-article","created":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T11:45:37Z","timestamp":1475840737000},"page":"637-642","source":"Crossref","is-referenced-by-count":17,"title":["Subjective Versus Objective Weight Gain During Acute Treatment With Second-Generation Antipsychotics in Schizophrenia and Bipolar Disorder"],"prefix":"10.1097","volume":"36","author":[{"given":"Keming","family":"Gao","sequence":"first","affiliation":[{"name":"From the *Mood and Anxiety Clinic in the Mood Disorders Program, Department of Psychiatry, Case Western Reserve University\/University Hospitals Cleveland Medical Center, Cleveland, OH; and \u2020Mood Disorders Program of Hongkou District Mental Health Center of Shanghai, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[{"name":"From the *Mood and Anxiety Clinic in the Mood Disorders Program, Department of Psychiatry, Case Western Reserve University\/University Hospitals Cleveland Medical Center, Cleveland, OH; and \u2020Mood Disorders Program of Hongkou District Mental Health Center of Shanghai, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuowei","family":"Wang","sequence":"additional","affiliation":[{"name":"From the *Mood and Anxiety Clinic in the Mood Disorders Program, Department of Psychiatry, Case Western Reserve University\/University Hospitals Cleveland Medical Center, Cleveland, OH; and \u2020Mood Disorders Program of Hongkou District Mental Health Center of Shanghai, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Calabrese","sequence":"additional","affiliation":[{"name":"From the *Mood and Anxiety Clinic in the Mood Disorders Program, Department of Psychiatry, Case Western Reserve University\/University Hospitals Cleveland Medical Center, Cleveland, OH; and \u2020Mood Disorders Program of Hongkou District Mental Health Center of Shanghai, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20231021","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1017\/S136898001400305X","article-title":"Large proportions of overweight and obese children, as well as their parents, underestimate children's weight status across Europe. The ENERGY (EuropeaN Energy balance Research to prevent excessive weight Gain among Youth) project","volume":"18","year":"2015","journal-title":"Public Health Nutr"},{"issue":"Suppl 1","key":"bib2-20231021","first-page":"S2","article-title":"Measuring the bias, precision, accuracy, and validity of self-reported height and weight in assessing overweight and obesity status among adolescents using a surveillance system","volume":"12","year":"2015","journal-title":"Int J Behav Nutr Phys Act"},{"key":"bib3-20231021","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/aje\/kwu133","article-title":"Accuracy of self-reported versus measured weight over adolescence and young adulthood: findings from the national longitudinal study of adolescent health, 1996\u20132008","volume":"180","year":"2014","journal-title":"Am J Epidemiol"},{"key":"bib4-20231021","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/josh.12195","article-title":"Body mass index self-perception and weight management behaviors during late adolescence","volume":"84","year":"2014","journal-title":"J Sch Health"},{"key":"bib5-20231021","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.3390\/ijerph6102696","article-title":"Validity of self-reported weight and height of adolescents, its impact on classification into BMI-categories and the association with weighing behaviour","volume":"6","year":"2009","journal-title":"Int J Environ Res Public Health"},{"key":"bib6-20231021","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.2196\/jmir.2909","article-title":"How accurate is web-based self-reported height, weight, and body mass index in young adults?","volume":"16","year":"2014","journal-title":"J Med Internet Res"},{"key":"bib7-20231021","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1017\/S1368980011003193","article-title":"Accuracy and reliability of self-reported weight and height in the Sister Study","volume":"15","year":"2012","journal-title":"Public Health Nutr"},{"key":"bib8-20231021","first-page":"72","article-title":"Sex and ethnic differences in validity of self-reported adult height, weight and body mass index","volume":"22","year":"2012","journal-title":"Ethn Dis"},{"key":"bib9-20231021","first-page":"M481","article-title":"Self-reported versus measured weight and height in an older adult meal program population","volume":"53","year":"1998","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"bib10-20231021","first-page":"77","article-title":"Effects of measurement on obesity and morbidity","volume":"19","year":"2008","journal-title":"Health Rep"},{"key":"bib11-20231021","doi-asserted-by":"crossref","first-page":"450","DOI":"10.5414\/CP202526","article-title":"Prevalence of overweight in schizophrenia patients in Asia: findings of the research on Asian psychotropic prescription patterns (REAP) study","volume":"54","year":"2016","journal-title":"Int J Clin Pharmacol Ther"},{"key":"bib12-20231021","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.psym.2010.12.009","article-title":"Association of psychiatric illness and obesity, physical inactivity, and smoking among a national sample of veterans","volume":"52","year":"2011","journal-title":"Psychosomatics"},{"key":"bib13-20231021","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/schbul\/sbs082","article-title":"Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients","volume":"39","year":"2013","journal-title":"Schizophr Bull"},{"key":"bib14-20231021","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/070674370104600610","article-title":"Body mass index in persons with schizophrenia","volume":"46","year":"2001","journal-title":"Can J Psychiatry"},{"key":"bib15-20231021","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1600-0447.2005.00637.x","article-title":"Obesity among individuals with serious mental illness","volume":"113","year":"2006","journal-title":"Acta Psychiatr Scand"},{"key":"bib16-20231021","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4088\/JCP.v63n0306","article-title":"Correlates of overweight and obesity in 644 patients with bipolar disorder","volume":"63","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"bib17-20231021","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/acps.12101","article-title":"General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial","volume":"129","year":"2014","journal-title":"Acta Psychiatr Scand"},{"key":"bib18-20231021","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/bdi.12035","article-title":"Obesity and the three-year longitudinal course of bipolar disorder","volume":"15","year":"2013","journal-title":"Bipolar Disord"},{"key":"bib19-20231021","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/070674370605100502","article-title":"Obesity in bipolar disorder and major depressive disorder: results from a national community health survey on mental health and well-being","volume":"51","year":"2006","journal-title":"Can J Psychiatry"},{"key":"bib20-20231021","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.schres.2009.05.030","article-title":"Effectiveness of second-generation antipsychotics with acute-phase schizophrenia","volume":"113","year":"2009","journal-title":"Schizophr Res"},{"key":"bib21-20231021","first-page":"CD008016","article-title":"Maintenance treatment with antipsychotic drugs for schizophrenia","volume":"5","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"bib23-20231021","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-1241.2007.01416.x","article-title":"Metabolic side effects of antipsychotic medication","volume":"61","year":"2007","journal-title":"Int J Clin Pract"},{"key":"bib24-20231021","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/JCP.0b013e31802e5126","article-title":"Second-generation antipsychotic exposure and metabolic- related disorders in patients with schizophrenia: an observational pharmacoepidemiology study from 1988 to 2002","volume":"27","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"bib25-20231021","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/JCP.0b013e318166c4d5","article-title":"Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review","volume":"28","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"bib26-20231021","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4088\/JCP.v69n0217","article-title":"A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence","volume":"69","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"bib27-20231021","first-page":"171","article-title":"Bridging disparate symptoms of schizophrenia: a triple network dysfunction theory","volume":"8","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"bib28-20231021","first-page":"113","article-title":"Subjective experience and mental side-effects of antipsychotic treatment","volume":"395","year":"1999","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"bib29-20231021","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0447.2007.01123.x","article-title":"Accuracy of body image perception and preferred weight loss strategies in schizophrenia: a controlled pilot study","volume":"117","year":"2008","journal-title":"Acta Psychiatr Scand"},{"key":"bib30-20231021","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.concog.2012.05.001","article-title":"Bodily self and schizophrenia: the loss of implicit self-body knowledge","volume":"21","year":"2012","journal-title":"Conscious Cogn"},{"key":"bib31-20231021","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/BF03261978","article-title":"Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis","volume":"35","year":"2012","journal-title":"Drug Saf"},{"key":"bib32-20231021","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1517\/14740338.2012.712682","article-title":"Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis","volume":"11","year":"2012","journal-title":"Expert Opin Drug Saf"},{"key":"bib33-20231021","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.4088\/JCP.09r05535gre","article-title":"Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychotics","volume":"72","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"bib34-20231021","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","year":"2013","journal-title":"Lancet"},{"issue":"Suppl 1","key":"bib35-20231021","first-page":"19","article-title":"Iloperidone: a clinical overview","volume":"72","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"bib36-20231021","article-title":"Is There a \u201cWeight Neutral\u201d Second-Generation Antipsychotic for Bipolar Disorder?","journal-title":"Expert Rev Neurother"},{"key":"bib37-20231021","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1874205X01307010023","article-title":"Antipsychotic drugs opposite to metabolic risk: neurotransmitters, neurohormonal and pharmacogenetic mechanisms underlying with weight gain and metabolic syndrome","volume":"7","year":"2013","journal-title":"Open Neurol J"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004714-201612000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T06:25:53Z","timestamp":1697869553000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201612000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0000000000000596","relation":{},"ISSN":["1533-712X","0271-0749"],"issn-type":[{"value":"1533-712X","type":"electronic"},{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}